TRIM5 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 7.46389999806141E-08 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.61513999999974E-05 |
Normal-vs-Stage2 |
9.778600E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
6.961100E-04 |
Stage1-vs-Stage2 |
5.613600E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
2.400000E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
5.755600E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.04939999987653E-07 |
Normal-vs-AfricanAmerican |
2.066400E-01 |
Normal-vs-Asian |
9.563500E-04 |
Caucasian-vs-AfricanAmerican |
3.069800E-01 |
Caucasian-vs-Asian |
7.482800E-01 |
AfricanAmerican-vs-Asian |
4.897800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.047000E-04 |
Normal-vs-Female |
1.67798999999302E-05 |
Male-vs-Female |
3.246400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
8.843700E-03 |
Normal-vs-Extreme_Weight |
1.823950E-04 |
Normal-vs-Obese |
5.282300E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
6.956200E-01 |
Normal_Weight-vs-Obese |
8.841800E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
8.121600E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.63029999999953E-05 |
Normal-vs-Age(41-60Yrs) |
2.23649999999687E-05 |
Normal-vs-Age(61-80Yrs) |
3.980500E-04 |
Normal-vs-Age(81-100Yrs) |
3.916200E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.247500E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.158230E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.168200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.306400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.479000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.909400E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
2.684200E-01 |
Normal-vs-Grade 3 |
3.256800E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
8.198400E-01 |
Grade 2-vs-Grade 4 |
2.684200E-01 |
Grade 3-vs-Grade 4 |
3.256800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.52919999998991E-06 |
Normal-vs-N1 |
1.063310E-03 |
N0-vs-N1 |
6.183200E-01 |
|
|